Sun Pharma Q1 net zooms over 3-fold to R2,033 cr

The Financial Express - - COMPANIES - PTI

New Delhi, Aug 12: Sun Phar­ma­ceu­ti­cal In­dus­tries’ con­sol­i­dated net profit zoomed more than 3-fold to

R2,033.71 crore for the first quar­ter ended June 30, 201617, on ac­count of ro­bust sales. It had posted net profit af­ter taxes, mi­nor­ity in­ter­est and share of profit of as­so­ci­ates and joint ven­tures of R555.90 crore for the cor­re­spond­ing pe­riod of the pre­vi­ous fis­cal, Sun Phar ma said in a BSE fil­ing.

The com­pany’s con­sol­i­dated to­tal in­come from op­er­a­tions rose to R8,242.99 crore for the first quar­ter of the cur­rent fis­cal, as against

R6,761.49 crore for the same pe­riod of 2015-16.

Sun Pharma stock closed 0.88% down at R801.80 on BSE.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.